Infectious diseases are a leading cause of illness and death worldwide, and are particularly dangerous to individuals with compromised immune systems. Immunocompromised people are less apt to control primary infection, more susceptible to developing complications from infections, and often afflicted by pathogens that rarely cause disease in the general population. The Infectious Disease Sciences Program at Fred Hutch seeks to improve detection, prevention, and treatment outcomes for infectious diseases, through targeted laboratory research and multi-site clinical trials.
Our physicians and scientists apply their extensive experience in immunocompetent and immunocompromised populations to study the epidemiology of infectious diseases, investigate emerging infectious diseases, develop novel diagnostic methods and perform clinical trials for new treatments for major infections. Specific areas of research focus include:
IDS houses major initiatives aimed at expediting research progress and improving clinical outcomes by fostering collaborations within the Hutch and around the world, while supporting our team-oriented approach to patient care. Through these initiatives, we seek to advance our understanding of infectious diseases, and to improve prevention and treatment of these diseases.
Director, Program Operations
Limei Fan oversees the diverse functions of IDS operations, including financial planning, grant and contract activities, personnel management, protocol management and regulatory compliance, faculty communication and administration, and scientific symposia, conferences and events.
She leads efforts to develop and implement program procedures, mentors staff, serves as senior project manager in major studies and manages affiliate relationships. Trained in executive leadership, and with a management background in private-public-education-business partnerships, Limei focuses on practical approaches to advance learning, optimize resources and provide excellent service.